Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors
about
Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugsOpposing effects of α2- and β-adrenergic receptor stimulation on quiescent neural precursor cell activity and adult hippocampal neurogenesis.Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.Efficient measurement of endogenous neurotransmitters in small localized regions of central nervous systems in vitro with HPLCThe potential role of dopamine D₃ receptor neurotransmission in cognition.Current management of the cognitive dysfunction in Parkinson's disease: how far have we come?Improving antidepressant drugs: update on recently patented compounds.1-Piperonylpiperazinium 4-chloro-benzoate.1-Piperonylpiperazinium 4-nitro-benzoate monohydrate.Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease.Comparative effects of the dopaminergic agonists piribedil and bromocriptine in three different memory paradigms in rodents.The Parkinson-Control study: a 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease.The frontal cortex as a network hub controlling mood and cognition: Probing its neurochemical substrates for improved therapy of psychiatric and neurological disorders.
P2860
Q28305100-5934805F-BE00-441A-80AE-CE16BD6B91FEQ33747754-8F623C68-7427-457E-A1B4-147E879F5147Q33893155-AE09862D-AFB6-4B15-89F8-6661DBB25E6CQ36740461-A701BFBC-ACC7-4ACC-AB39-5456F6502207Q37106827-65D548C1-CAA0-4F24-B8EF-AD242212A311Q37183932-2EC148E2-2812-466F-9509-5EBA98BCF2AEQ37497379-F9E50018-37D7-4E24-9920-2B116E998C99Q37721168-15FC35E9-7D00-4096-AF0E-2C7ADE9A5D61Q37721219-8922295A-58A8-4C5D-A870-0178C6119088Q38877254-45C42065-E73D-4FD7-8C76-B30751703647Q46727000-F5A6F043-98EA-447A-A9BA-FC28D0E9D632Q46789074-27FDFB40-7DCF-4A0B-AFB1-8E23DF59A5FCQ47382890-36B9B251-DD57-4A6E-8558-DE0837FD5FFC
P2860
Piribedil enhances frontocortical and hippocampal release of acetylcholine in freely moving rats by blockade of alpha 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@ast
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@en
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@nl
type
label
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@ast
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@en
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@nl
prefLabel
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@ast
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@en
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@nl
P2093
P356
P1476
Piribedil enhances frontocorti ...... cetylcholinesterase inhibitors
@en
P2093
L Cistarelli
M J Millan
P304
P356
10.1124/JPET.102.046383
P407
P577
2003-04-01T00:00:00Z